Current Therapy of Type 2 Diabetes Mellitus using a Sample of SulfonylureaG — Prolonged Releasing Gliclazide Produced by Pharmak, Ltd (Kyiv, Ukraine)

Abstract

The paper describes the efficacy of sulfonylurea derivative — domestic medication Dіaglizide MR (Farmak, Ltd) in the treatment of type 2 diabetes mellitus. The efficacy and safety of the agent confirmed in scientific studies allow recommend it for the treatment of type 2 diabetes mellitus.

Authors and Affiliations

O. Yu. Mykhailenko

Keywords

Related Articles

Peculiarities of Ischemic Heart Disease Course and Treatment in Patients with Glucose Metabolism Impairment and Diabetes Mellitus

Combination of ischemic heart disease and diabetes mellitus is characterized by certain features of clinical picture and insufficient effectiveness of treatment of ischemic heart disease. With the aim of investigation of...

Clinical experience of using herbal medicinal product Glucemedin in the comprehensive treatment of patients with type 2 diabetes mellitus

Background. The current task of treating patients with type 2 diabetes mellitus and dyslipoproteinemia is the analysis of efficiency of the combination of standard hypoglycemic agents with phytotherapeutic drugs, but inf...

State of the Thyroid and Mammary Glands in Women with Secondary Infertility and Early Reproductive Losses in Past Medical History

The article presents the results of studying the thyroid and mammary glands in women (n = 203) with secondary infertility and early reproductive losses in past medical history (pregnant women with threatened miscarriage,...

Мonocyte Chemoattractant Protein Levels in Patients with Primary Hypothyroidism

Objective of the research — ​to study the content of monocyte chemoattractant protein‑1 (MCP‑1) in the urine of patients with primary hypothyroidism. Materials and methods. 141 patients with overt hypothyroidism have bee...

Male factor of sterility: algorithm of laboratory diagnosis of the causes (part 2)

Previously, the topics of laboratory diagnosis were covered: assessment of the male androgenic status: what to choose — total or free testosterone; or use an estimated indicator — free testosterone index; what is importa...

Download PDF file
  • EP ID EP222658
  • DOI -
  • Views 29
  • Downloads 0

How To Cite

O. Yu. Mykhailenko (2015). Current Therapy of Type 2 Diabetes Mellitus using a Sample of SulfonylureaG — Prolonged Releasing Gliclazide Produced by Pharmak, Ltd (Kyiv, Ukraine). Міжнародний ендокринологічний журнал, 2(66), 52-56. https://europub.co.uk/articles/-A-222658